Using flow cytometry analysis, the flagellin of Burkholderia pseudomallei acts as a signalling inducer, and evokes an increase in the intracellular calcium ion concentration ([Ca2+]i) in human peripheral blood mononuclear cells (PBMC). The cells with increased [Ca2+]i segregate into the live monocyte gate and not into the live lymphocyte gates. The stimulated [Ca2+]i increase can be neutralized with anti‐flagellin antibodies. In the absence of [Ca2+], [Ca2+]i was increased rapidly in flagellin‐treated cells compared to non‐flagellin‐treated cells only after the addition of 1 mM CaCl2. Selective calcium antagonists were used to effectively block the [Ca2+]i signal, revealing that this signal was decreased by the addition of L‐type calcium channel blockers (diltiazem, nifedipine and verapamil) and La2+ but was not changed by the addition of a T‐type calcium channel blocker (flunarizine). It seemed that flagellin facilitates [Ca2+]i influx via a La2+ sensitive L‐type cellular membrane channel. Furthermore, flagellin also acts as a TNF‐α inducer in a time‐ and concentration‐dependent manner when adhered mononuclear cells are treated with flagellin. This ability to induce TNF‐α production was affected by the presence of [Ca2+] in the culture medium. It suggested that B. pseudomallei flagellin is an immuno‐stimulatory molecule, causing an increase in [Ca2+]i and an up‐regulation of TNF‐α, which may play an important role in the inflammation process.